Skip to content
10-Q

Quarterly Report

WEIKANG BIO-TECHNOLOGY GROUP CO., INC.

0001144204-12-029203

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 14, 2012 34.77M sh
Shares Diluted Q1 2012 · Mar 31, 2012 34.45M sh
Shares Diluted Q1 2012 · Mar 31, 2011 30.67M sh
Operating Cash Flow Q1 2012 · Mar 31, 2012 $9.74M
Operating Cash Flow Q1 2012 · Mar 31, 2011 $10.58M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $80.62M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $70.78M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $61.82M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $50.36M
Stockholders Equity Q1 2012 · Mar 31, 2012 $118.81M
Stockholders Equity Q1 2012 · Dec 31, 2011 $112.1M
Stockholders Equity Q1 2012 · Dec 31, 2010 $66.93M
Current Liabilities Q1 2012 · Mar 31, 2012 $6.36M
Current Liabilities Q1 2012 · Dec 31, 2011 $7.56M
Total Liabilities Q1 2012 · Mar 31, 2012 $9.81M
Total Liabilities Q1 2012 · Dec 31, 2011 $11.09M
Current Assets Q1 2012 · Mar 31, 2012 $87.73M
Current Assets Q1 2012 · Dec 31, 2011 $81.85M
Total Assets Q1 2012 · Mar 31, 2012 $128.62M
Total Assets Q1 2012 · Dec 31, 2011 $123.19M
Eps Diluted Q1 2012 · Mar 31, 2012 $0.19
Eps Diluted Q1 2012 · Mar 31, 2011 $0.37
Eps Basic Q1 2012 · Mar 31, 2012 $0.19
Eps Basic Q1 2012 · Mar 31, 2011 $0.37
Sga Expense Q1 2012 · Mar 31, 2012 $592.72K
Sga Expense Q1 2012 · Mar 31, 2011 $1.57M
Net Income Q1 2012 · Mar 31, 2012 $6.58M
Net Income Q1 2012 · Dec 31, 2011 $29.63M
Net Income Q1 2012 · Mar 31, 2011 $11.31M
Operating Income Q1 2012 · Mar 31, 2012 $8.68M
Operating Income Q1 2012 · Mar 31, 2011 $15.16M
Gross Profit Q1 2012 · Mar 31, 2012 $9.93M
Gross Profit Q1 2012 · Mar 31, 2011 $17.67M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $7.75M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $10.49M
Revenue Q1 2012 · Mar 31, 2012 $17.67M
Revenue Q1 2012 · Mar 31, 2011 $28.16M